Display options
Cite
Kanojia D, Sawant SS, Borges AM, et al. Alterations in keratins and associated proteins during 4- Nitroquinoline-1-oxide induced rat oral carcinogenesis. J Carcinog. 2012;11:14doi: 10.4103/1477-3163.100861.
Kanojia, D., Sawant, S. S., Borges, A. M., Ingle, A. D., & Vaidya, M. M. (2012). Alterations in keratins and associated proteins during 4- Nitroquinoline-1-oxide induced rat oral carcinogenesis. Journal of carcinogenesis, 1114. https://doi.org/10.4103/1477-3163.100861
Kanojia, Deepak, et al. "Alterations in keratins and associated proteins during 4- Nitroquinoline-1-oxide induced rat oral carcinogenesis." Journal of carcinogenesis vol. 11 (2012): 14. doi: https://doi.org/10.4103/1477-3163.100861
Kanojia D, Sawant SS, Borges AM, Ingle AD, Vaidya MM. Alterations in keratins and associated proteins during 4- Nitroquinoline-1-oxide induced rat oral carcinogenesis. J Carcinog. 2012;11:14. doi: 10.4103/1477-3163.100861. Epub 2012 Sep 13. PMID: 23233820; PMCID: PMC3516248.
Copy Download .nbib Format: NLM
Share it on

J Carcinog. 2012;11:14. doi: 10.4103/1477-3163.100861. Epub 2012 Sep 13.

Alterations in keratins and associated proteins during 4- Nitroquinoline-1-oxide induced rat oral carcinogenesis.

Journal of carcinogenesis

Deepak Kanojia, Sharada S Sawant, Anita M Borges, Arvind D Ingle, Milind M Vaidya

Affiliations

  1. Department of Biological Science, University of South Carolina, Columbia, SC, USA.

PMID: 23233820 PMCID: PMC3516248 DOI: 10.4103/1477-3163.100861

Abstract

BACKGROUND: Oral squamous cell carcinoma (OSCC) is the sixth largest group of malignancies globally and the single largest group of malignancies in the Indian subcontinent. Despite the advances in treatment and therapeutic modalities the five year survival rate of OSCC has not changed in the last few decades, and remains less than 40%. Several studies have focused on defining molecular markers that can either detect cancer at an early stage or can predict patient's outcome. However, such markers are still undefined. Keratins (K) are epithelia predominant intermediate filament proteins which are expressed in a differentiation dependent and site specific manner. Keratins are being used as biomarkers in different epithelial disorders including cancer. They are associated with desmoplakin and α6β4 integrin which are components of desmosomes and hemidesmosomes respectively.

MATERIALS AND METHODS: 4-Nitroquinoline 1-Oxide (4NQO) was used as a carcinogen for the development of various stages of oral carcinogenesis in rat lingual mucosa. Two-Dimentional gel electrophoresis was performed for the separation of Keratins followed by western blotting for their specific identification. Western blotting and RT PCR was carried out for desmoplakin and α6β4 integrin respectively to understand their levels. Immunohistochemical analysis was carried out to further study the localization of desmoplakin and α6 integrin.

RESULTS: In this study we have analysed the alterations in Keratins and associated proteins during sequential stages of 4NQO induced rat oral carcinogenesis. Our results showed that the alterations primarily begin after the dysplastic changes in the lingual epithelium like the elevation of Keratins 5/6a, ectopic expression of Keratin 8, increase in suprabasal expression of α6 integrin and increase in desmoplakin levels. Most of these alterations persisted till the development of SCC except desmoplakin, the levels of which were downregulated in papillomatous lesions and SCC. Many of these alterations have also been documented in human oral carcinogensis.

CONCLUSION: Thus, 4NQO model of rat lingual carcinogenesis reproduces majority of the changes that are seen in human oral carcinogenesis and it can be exploited for the development of biomarkers.

Keywords: 4- Nitroquinoline-1-oxide; Biomarkers; Desmoplakin; Keratin; Rat oral carcinogenesis; Squamous cell carcinoma; α6β4 integrin

References

  1. Science. 1992 Nov 6;258(5084):955-64 - PubMed
  2. J Biosci. 2007 Jun;32(4):629-34 - PubMed
  3. Anal Biochem. 1977 Dec;83(2):346-56 - PubMed
  4. J Oral Pathol Med. 1992 Jan;21(1):7-11 - PubMed
  5. Cancer Res. 2005 Aug 1;65(15):6551-6 - PubMed
  6. CA Cancer J Clin. 2002 Jul-Aug;52(4):195-215 - PubMed
  7. Mol Carcinog. 1997 Sep;20(1):3-9 - PubMed
  8. Oral Oncol. 2005 Apr;41(4):337-9 - PubMed
  9. Cell. 1982 Nov;31(1):11-24 - PubMed
  10. BMC Cancer. 2006 Jan 13;6:10 - PubMed
  11. Oral Oncol. 1998 May;34(3):204-10 - PubMed
  12. J Cell Sci. 2011 Jun 15;124(Pt 12):2096-106 - PubMed
  13. IARC Sci Publ. 1998;(145):135-73 - PubMed
  14. J Oral Pathol Med. 1993 Feb;22(2):82-6 - PubMed
  15. Int J Oral Maxillofac Surg. 2003 Jun;32(3):233-45 - PubMed
  16. J Natl Cancer Inst. 1990 Oct 3;82(19):1566-72 - PubMed
  17. Pathobiology. 1994;62(3):127-33 - PubMed
  18. Cancer Res. 1992 May 15;52(10):2966-76 - PubMed
  19. Hum Pathol. 2009 Sep;40(9):1320-9 - PubMed
  20. Int J Cancer. 2004 Sep 20;111(5):662-8 - PubMed
  21. N Engl J Med. 2001 Apr 26;344(17):1323-6 - PubMed
  22. Eur J Oral Sci. 1999 Jun;107(3):183-93 - PubMed
  23. Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):973-8 - PubMed
  24. Oral Oncol. 1998 Jul;34(4):261-4 - PubMed
  25. Oral Oncol. 2006 Aug;42(7):655-67 - PubMed
  26. Eur J Cancer B Oral Oncol. 1996 Sep;32B(5):333-6 - PubMed
  27. Head Neck. 1995 Mar-Apr;17(2):140-7 - PubMed
  28. Methods Enzymol. 1986;134:355-71 - PubMed
  29. Int J Cancer. 2002 Jan 1;97(1):72-81 - PubMed
  30. Environ Health Perspect. 2008 Apr;116(4):434-40 - PubMed

Publication Types